Recursion Pharmaceuticals Inc Clas (RXRX)

Cash & Short-Term Investments

$545.68M

Quarterly · Period ending: · USD

RXRX logo

RXRX Cash & Short-Term Investments

Latest reported$545.68M
RXRX Quarterly Cash & Short-Term Investments ($69.88M → $545.68M)
High-resolution chart · PNG

RXRX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
545,683,000
654,473,000
743,294,000
659,836,000
528,216,000
500,453,000
594,350,000
427,647,000
474,341,000
299,521,000
391,565,000
387,322,000
405,870,000
473,145,000
549,912,000
454,646,000
515,436,000
591,105,000
516,562,000
578,910,000
632,738,000
214,088,000
262,126,000
69,883,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.